Stretch Marks Fading: Labs, Causes, and Next Steps

Why Stretch Marks Fade Over Time

Stretch marks begin as inflammatory lesions in the dermis where rapid mechanical stretching has torn elastic fibers and disrupted collagen bundles. The initial red or purple color (striae rubrae) reflects increased vascularity and active inflammation in the dermis 1. Over weeks to months, the inflammatory infiltrate resolves, blood vessels regress, and the lesion transitions into a pale, atrophic scar (striae alba) with flattened epidermis and horizontally aligned collagen 2.

Histologically, mature striae alba resemble scar tissue. Elastic fibers are absent or fragmented, and the dermis thins by roughly 25 to 50% compared with surrounding normal skin 3. This atrophy explains the characteristic sunken, shiny texture. The transition from rubrae to alba is driven by the same wound-healing cascade that governs scar maturation anywhere on the body: an initial inflammatory phase gives way to proliferation and then remodeling, during which type III collagen is gradually replaced by type I collagen 4.

Not all striae fade at the same rate. Marks on the abdomen may take 12 to 18 months to fully lighten, while those on the thighs or breasts sometimes remain pink for two years or longer 5. Darker skin tones frequently show hyperpigmented rather than hypopigmented end-stage striae, a variant sometimes called striae nigrae. Genetic factors also affect speed of resolution. Variants in the ELN (elastin) and FBN1 (fibrillin-1) genes have been associated with increased susceptibility to striae and with altered dermal remodeling kinetics 6.

Common Causes of Stretch Marks

The most frequent triggers for striae formation are pregnancy, adolescent growth spurts, and rapid weight gain or loss. A prospective cohort study found that 88% of primigravid women developed striae gravidarum, with risk increasing alongside younger maternal age, higher pre-pregnancy BMI, and greater gestational weight gain 7. Adolescent striae are similarly common. Surveys estimate that 40 to 70% of teenagers develop them during puberty, particularly on the thighs, hips, and lumbosacral region 8.

Rapid body composition changes linked to GLP-1 receptor agonist therapy or bariatric surgery can trigger new striae or accelerate the fading of existing ones as skin tension decreases. Weight loss of 10% or more over a short period changes mechanical loading on the dermis significantly 9.

Exogenous and endogenous glucocorticoid excess remains the most clinically important secondary cause. Prolonged use of topical corticosteroids (especially high-potency formulations under occlusion) thins the dermis and promotes striae in areas of application 10. Endogenous hypercortisolism (Cushing syndrome) classically produces wide (greater than 1 cm), violaceous striae on the abdomen, axillae, and proximal thighs. The Endocrine Society's 2008 clinical practice guideline identifies wide purple striae as one of the discriminating features of Cushing syndrome with high diagnostic specificity 11.

When Fading Stretch Marks Warrant Lab Testing

Most stretch marks need zero laboratory evaluation. Fading is the expected natural course. Lab work becomes necessary when the clinical picture does not match a benign etiology.

Red flags that should prompt testing include: striae wider than 1 cm, striae in unusual locations such as the face or dorsal hands, concurrent signs of cortisol excess (proximal muscle weakness, central obesity, facial plethora, easy bruising), striae appearing without any identifiable trigger of mechanical stretching, and striae in prepubertal children 12.

The Endocrine Society recommends initial Cushing syndrome screening with at least two of the following tests: late-night salivary cortisol (two measurements), 24-hour urinary free cortisol (two collections), or overnight 1-mg dexamethasone suppression test 11. Salivary cortisol has a sensitivity of approximately 92 to 100% and a specificity of 93 to 100% when the appropriate reference range is used 13.

Beyond cortisol evaluation, clinicians may order serum DHEA-S to screen for adrenal androgen excess, a thyroid panel (TSH and free T4) if there are signs of thyroid dysfunction contributing to skin changes, and fasting glucose or hemoglobin A1c if metabolic syndrome is suspected as a driver of body composition shifts 14. For adolescents with unexplained striae that do not correspond to a growth spurt, growth hormone and IGF-1 levels may be checked to evaluate for conditions such as Marfan syndrome, where connective tissue fragility leads to striae independent of stretching 15.

Lab Tests Explained

Late-night salivary cortisol. This test captures the loss of normal circadian cortisol rhythm. Patients collect saliva between 11 p.m. and midnight on two separate nights. Elevated values on both collections strongly suggest Cushing syndrome 13. The test is noninvasive and can be completed at home, which is why the Endocrine Society lists it as a first-line screen 11.

24-hour urinary free cortisol. Measures total cortisol output over a full day. Values more than three to four times the upper limit of normal are nearly diagnostic. Mild elevations require repeat testing to distinguish from pseudo-Cushing states related to depression, alcoholism, or severe obesity 16.

1-mg overnight dexamethasone suppression test. The patient takes 1 mg of dexamethasone at 11 p.m. and draws a morning cortisol at 8 a.m. Failure to suppress cortisol below 1.8 mcg/dL (50 nmol/L) is considered a positive screen. Specificity improves to above 95% at this cutoff 11.

Serum DHEA-S. Elevated DHEA-S can point to an adrenal source of androgen excess. In women, this may manifest as striae alongside acne, hirsutism, and menstrual irregularity 17.

TSH and free T4. While thyroid dysfunction is not a primary cause of striae, hypothyroidism can impair collagen synthesis and skin repair, altering how existing stretch marks remodel 18.

Treatment Options for Fading Stretch Marks

Treatment strategy depends on the stage of the stretch mark. Active rubrae-stage striae respond better to intervention than mature alba-stage lesions.

Topical retinoids. A randomized controlled trial by Kang et al. found that topical tretinoin 0.1% cream applied daily for six months significantly improved the clinical appearance of early striae, with histologic evidence of new collagen formation in the papillary dermis 19. A separate study using 0.05% tretinoin demonstrated a 14% reduction in mean striae length after six months compared to vehicle 20. Tretinoin is contraindicated during pregnancy and lactation.

Pulsed dye laser (PDL). The 585-nm or 595-nm PDL targets hemoglobin in the vascular rubrae stage. A systematic review by Defined Dermatology criteria found PDL produced consistent improvement in erythema and overall appearance of striae rubrae, though effect sizes varied 21. Multiple sessions (three to six at four-week intervals) are typically required.

Fractional CO2 laser. For mature striae alba, ablative fractional lasers create microthermal zones that stimulate neocollagenesis. A randomized split-body study showed fractional CO2 laser improved striae alba texture by 50 to 75% on blinded photographic assessment after three sessions 22.

Microneedling. Percutaneous collagen induction using microneedling devices (1.0 to 1.5 mm needle depth) has demonstrated improvement in striae alba comparable to fractional laser in several small comparative trials 23. It is less expensive and has minimal downtime.

Platelet-rich plasma (PRP). When combined with microneedling or fractional laser, PRP may enhance collagen remodeling. A split-body RCT showed significantly greater improvement in striae alba on the PRP-treated side versus microneedling alone 24.

Dr. Tina Alster, director of the Washington Institute of Dermatologic Laser Surgery, has stated: "The window for treating stretch marks most effectively is during the rubrae phase, when the tissue is still metabolically active and responsive to collagen-stimulating therapies" 21.

Prevention: What Does and Does Not Work

Prevention data are surprisingly thin. A 2012 Cochrane review evaluating topical preparations for preventing stretch marks in pregnancy concluded that neither cocoa butter, olive oil, nor any other commercially marketed cream demonstrated a significant preventive effect versus placebo 25. The review included six trials with a combined 800 participants.

Centella asiatica extract (also called Gotu kola) has the most promising preliminary evidence for prevention. A small trial showed reduced incidence of striae gravidarum when Centella-based cream was applied from the second trimester, possibly through stimulation of type I collagen and fibronectin synthesis 26. These results have not been confirmed in large, well-powered RCTs.

The American College of Obstetricians and Gynecologists (ACOG) does not recommend any specific topical product for striae prevention during pregnancy 27. ACOG's guidance instead emphasizes that gradual weight gain within recommended ranges is the most evidence-based strategy for reducing stretch mark risk, though genetic predisposition remains the dominant determinant.

Hyaluronic acid-based formulations have shown modest benefit in one industry-sponsored trial, reducing striae severity scores versus control during the third trimester 28. Independent replication is needed.

When to See a Specialist

A dermatologist should evaluate stretch marks when the appearance is cosmetically distressing and a patient wants to discuss laser or procedural options. An endocrinologist should be consulted if screening labs reveal elevated cortisol, suppressed dexamethasone results, or markedly elevated DHEA-S 11.

Dr. Lynnette Nieman, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH), has noted: "Wide, purple striae in a patient with centripetal obesity and proximal myopathy should be considered Cushing syndrome until proven otherwise" 16.

Urgent referral is appropriate for any child with unexplained wide striae (Cushing syndrome in pediatric patients can result from adrenal tumors requiring surgical intervention), for patients on chronic corticosteroids who develop rapidly worsening striae (dose adjustment or steroid-sparing agents should be discussed), and for anyone with striae accompanied by joint hypermobility and tall stature (screening for Marfan syndrome with echocardiography and genetic testing is indicated) 15.

Patients using GLP-1 receptor agonists such as semaglutide or tirzepatide who experience rapid weight loss should be counseled that existing stretch marks may change in appearance as subcutaneous fat volume decreases. The marks may appear more prominent temporarily before skin remodeling catches up 9. This is cosmetic, not dangerous, but patients should be informed so they can distinguish it from new pathology.

For women with striae gravidarum that have faded to alba and remain cosmetically bothersome postpartum, the earliest safe time to begin tretinoin is after cessation of breastfeeding 19. Fractional laser treatments can begin six months postpartum once hormonal skin changes have stabilized.